Paxil Linked to Birth Defects
GlaxoSmithKline and the FDA recently added precautions to Paxil and Paxil CR to reflect the results of a retrospectice epidemiological study indicating an increase in birth defects in those women taking the drug in the first trimester of pregnancy. The letter from GSK to physicians is found here.
Post A Comment / Question